title: Reprogrammed pluripotent stem cells from somatic cells.
abstract: Pluripotent stem cells, such as embryonic stem (ES) cells, can differentiate into all cell types. So, these cells can be a biological resource for regenerative medicine. However, ES cells known as standard pluripotent cells have problem to be used for cell therapy because of ethical issue of the origin and immune response on the graft. Hence, recently reprogrammed pluripotent cells have been suggested as an alternative source for regenerative medicine. Somatic cells can acquire the ES cell-like pluripotency by transferring somatic cell nuclei into oocytes, by cell fusion with pluripotent cells. Retroviral-mediated introduction of four factors, Oct4, Sox2, Klf4 and c-Myc can successfully reprogram somatic cells into ES cell-like pluripotent stem cells, known as induced pluripotent stem (iPS) cells. These cells closely resemble ES cells in gene expression pattern, cell biologic and phenotypic characteristics. However, to reach the eventual goal of clinical application, it is necessary to overcome the major drawbacks such as low reprogramming efficiency and genomic alterations due to viral integration. In this review, we discuss the current reprogramming techniques and mechanisms of nuclear reprogramming induced by transcription factor transduction.
authors.affiliation: Laboratory of Stem Cell and Developmental Biology, Department of Life Science, CHA University, Seoul, Korea.
authors.forename: Jong Soo
authors.initials: JS
authors.lastname: Kim
authors.forename: Hyun Woo
authors.initials: HW
authors.lastname: Choi
authors.forename: Sol
authors.initials: S
authors.lastname: Choi
authors.forename: Jeong Tae
authors.initials: JT
authors.lastname: Do
keywords: Cell fusion hybrid; Embryonic stem cell; Induced pluripotent stem cell; Pluripotency; Somatic cell nuclear transfer